MedPath

Feasibility of ESWT Treatment in Post-stroke Patients With Triceps Sural Spasticity

Not Applicable
Conditions
Stroke
Interventions
Procedure: ESWT + Stretching
Procedure: ESWT and SHAM + Stretching
Registration Number
NCT05255549
Lead Sponsor
Azienda Unità Sanitaria Locale Reggio Emilia
Brief Summary

The main objective is to evaluate the feasibility of two different rehabilitation protocols that differed from the number of treatment sessions (1 session of ESWT versus 3 weekly sessions of ESWT), in patients with triceps surae spasticity after stroke. In both arms the other ESWT parameters (types of ESWT, intensity, frequency, location) and stretching sessions are the same.

Secondary objectives: to compare functional performances in these two groups of patients receiving the different rehabilitation protocol with ESWT, using the following parameters:

- Six Minutes walking test (6MWT) ; - Time Up \& Go (TUG); - Modified Ashworth scale (MAS); - Lower Extremity Functional Scale (LEFS); - passive ankle range of motion (p-ROM), pain (NRS); and presence of ankle clonus. These parameters are assessed during baseline (T0), after 4 weeks (T1) and after 12 weeks (T2).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Adult patients of legal age
  • Time elapsed since the stroke between 6 and 60 months
  • Autonomous or supervised walking with or without aids
  • Spasticity of the sural triceps> 1 on the MAS scale
Exclusion Criteria
  • Joint stiffness of the lower limbs due to other pathologies (ex orthopedic or rheumatological);
  • Conditions that interfere with evaluation or collaboration in rehabilitation treatment (major psychiatric illnesses, clearly detectable cognitive deficits, severe pre-existing disabilities, sensory disturbances, etc.)
  • Focal antispasmodic toxin treatments in the previous 3 months or phenolic blocks in the previous 9 months in the treatment region
  • Treatments with central antispasmodic drugs with dosage modifications in the last week of starting treatment
  • Individual neurorehabilitation treatments in progress

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group IESWT + Stretching-
Group IIESWT and SHAM + Stretching-
Primary Outcome Measures
NameTimeMethod
Feasibility of two kind treatments proposedT1 after 4 weeks from T0 (Enrollment)

The intervention is feasible if at least 80% of the enrolled patients complete the entire treatment foreseen in the allocation group

Secondary Outcome Measures
NameTimeMethod
Change in Walking ResistanceT0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0

6 minute walking test

Change in Level of mobility and balanceT0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0

Timed Up \& Go Test

Change in spasticityT0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0

Modified Ashworth Scale (MAS). Score from 0 to 4, higher scores mean a worse outcome

Change in Passive ROM of the ankle in dorsiflexionT0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0

Passive ankle Range of Motion (p-ROM)

Change in Leg PainT0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0

Numeric Pain Rating Scale (NPRS) Score from 0 to 10, higher scores mean a worse outcome

Change in Ability to carry out activities of daily livingT0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0

Lower Extremity Functional Scale (LEFS). Score from 0 to 80, higher scores mean a better outcome.

Change in triceps clonesT0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0

Presence of ankle clonus

Trial Locations

Locations (1)

Operational Unit of Physical Medicine and Rehabilitation AUSL - IRCCS Reggio Emilia

🇮🇹

Reggio Emilia, Emilia Romagna, Italy

© Copyright 2025. All Rights Reserved by MedPath